VERWENDUNG VON ESTROGEN ZUR VERHÜTUNG ODER KONTROLLE VON KATARAKT
A method for preventing or treating pathological changes which occur in association with cataract formation in the mammalian eye by protecting lens cells against the cataractogenic effects of transforming growth factor-beta (TGFbeta). Estrogen or an estrogenic substance can be administered to the ma...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | CHAMBERLAIN, CORAL, GWENDA HALES, ANGELA, MARIA MCAVOY, JOHNSTON, WILLIAM |
| description | A method for preventing or treating pathological changes which occur in association with cataract formation in the mammalian eye by protecting lens cells against the cataractogenic effects of transforming growth factor-beta (TGFbeta). Estrogen or an estrogenic substance can be administered to the mammal or directly to or near the eye of the mammal. The means of administration can be by a pharmaceutical composition comprising estrogen, a membranous ocular patch impregnated with estrogen or a lens or lens implant coated or impregnated with estrogen. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ATE309842TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ATE309842TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ATE309842TT13</originalsourceid><addsrcrecordid>eNrjZHAKcw0Kd_VzCfVzVwjz91NwDQ4J8nd39VOICg1SAMp5HJ4TApLzd3ENUvD29wPK-vi4gpV6O4Y4Bjl6h_AwsKYl5hSn8kJpbgZFN9cQZw_d1IL8-NTigsTk1LzUknjHEFdjA0sLE6OQEENjYtQAALTiLRs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>VERWENDUNG VON ESTROGEN ZUR VERHÜTUNG ODER KONTROLLE VON KATARAKT</title><source>esp@cenet</source><creator>CHAMBERLAIN, CORAL, GWENDA ; HALES, ANGELA, MARIA ; MCAVOY, JOHNSTON, WILLIAM</creator><creatorcontrib>CHAMBERLAIN, CORAL, GWENDA ; HALES, ANGELA, MARIA ; MCAVOY, JOHNSTON, WILLIAM</creatorcontrib><description>A method for preventing or treating pathological changes which occur in association with cataract formation in the mammalian eye by protecting lens cells against the cataractogenic effects of transforming growth factor-beta (TGFbeta). Estrogen or an estrogenic substance can be administered to the mammal or directly to or near the eye of the mammal. The means of administration can be by a pharmaceutical composition comprising estrogen, a membranous ocular patch impregnated with estrogen or a lens or lens implant coated or impregnated with estrogen.</description><edition>7</edition><language>ger</language><subject>CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, ORSURGICAL ARTICLES ; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR ; HUMAN NECESSITIES ; HYGIENE ; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICALARTICLES ; MEDICAL OR VETERINARY SCIENCE ; METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS INGENERAL ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2005</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20051215&DB=EPODOC&CC=AT&NR=E309842T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20051215&DB=EPODOC&CC=AT&NR=E309842T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CHAMBERLAIN, CORAL, GWENDA</creatorcontrib><creatorcontrib>HALES, ANGELA, MARIA</creatorcontrib><creatorcontrib>MCAVOY, JOHNSTON, WILLIAM</creatorcontrib><title>VERWENDUNG VON ESTROGEN ZUR VERHÜTUNG ODER KONTROLLE VON KATARAKT</title><description>A method for preventing or treating pathological changes which occur in association with cataract formation in the mammalian eye by protecting lens cells against the cataractogenic effects of transforming growth factor-beta (TGFbeta). Estrogen or an estrogenic substance can be administered to the mammal or directly to or near the eye of the mammal. The means of administration can be by a pharmaceutical composition comprising estrogen, a membranous ocular patch impregnated with estrogen or a lens or lens implant coated or impregnated with estrogen.</description><subject>CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, ORSURGICAL ARTICLES</subject><subject>DISINFECTION, STERILISATION, OR DEODORISATION OF AIR</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICALARTICLES</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS INGENERAL</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2005</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHAKcw0Kd_VzCfVzVwjz91NwDQ4J8nd39VOICg1SAMp5HJ4TApLzd3ENUvD29wPK-vi4gpV6O4Y4Bjl6h_AwsKYl5hSn8kJpbgZFN9cQZw_d1IL8-NTigsTk1LzUknjHEFdjA0sLE6OQEENjYtQAALTiLRs</recordid><startdate>20051215</startdate><enddate>20051215</enddate><creator>CHAMBERLAIN, CORAL, GWENDA</creator><creator>HALES, ANGELA, MARIA</creator><creator>MCAVOY, JOHNSTON, WILLIAM</creator><scope>EVB</scope></search><sort><creationdate>20051215</creationdate><title>VERWENDUNG VON ESTROGEN ZUR VERHÜTUNG ODER KONTROLLE VON KATARAKT</title><author>CHAMBERLAIN, CORAL, GWENDA ; HALES, ANGELA, MARIA ; MCAVOY, JOHNSTON, WILLIAM</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ATE309842TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>ger</language><creationdate>2005</creationdate><topic>CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, ORSURGICAL ARTICLES</topic><topic>DISINFECTION, STERILISATION, OR DEODORISATION OF AIR</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICALARTICLES</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS INGENERAL</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CHAMBERLAIN, CORAL, GWENDA</creatorcontrib><creatorcontrib>HALES, ANGELA, MARIA</creatorcontrib><creatorcontrib>MCAVOY, JOHNSTON, WILLIAM</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CHAMBERLAIN, CORAL, GWENDA</au><au>HALES, ANGELA, MARIA</au><au>MCAVOY, JOHNSTON, WILLIAM</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>VERWENDUNG VON ESTROGEN ZUR VERHÜTUNG ODER KONTROLLE VON KATARAKT</title><date>2005-12-15</date><risdate>2005</risdate><abstract>A method for preventing or treating pathological changes which occur in association with cataract formation in the mammalian eye by protecting lens cells against the cataractogenic effects of transforming growth factor-beta (TGFbeta). Estrogen or an estrogenic substance can be administered to the mammal or directly to or near the eye of the mammal. The means of administration can be by a pharmaceutical composition comprising estrogen, a membranous ocular patch impregnated with estrogen or a lens or lens implant coated or impregnated with estrogen.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | ger |
| recordid | cdi_epo_espacenet_ATE309842TT1 |
| source | esp@cenet |
| subjects | CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, ORSURGICAL ARTICLES DISINFECTION, STERILISATION, OR DEODORISATION OF AIR HUMAN NECESSITIES HYGIENE MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICALARTICLES MEDICAL OR VETERINARY SCIENCE METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS INGENERAL PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | VERWENDUNG VON ESTROGEN ZUR VERHÜTUNG ODER KONTROLLE VON KATARAKT |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T06%3A06%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CHAMBERLAIN,%20CORAL,%20GWENDA&rft.date=2005-12-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EATE309842TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |